Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Gastrointestinal 64Head & Neck 10Breast 7Genitourinary 4Thoracic 3Myeloid 2Other hematologic neoplasm 1Other 1

Conditions

Leukemia, Myeloid, Acute 3102Precursor Cell Lymphoblastic Leukemia-Lymphoma 2086Leukemia 2013Leukemia, Lymphocytic, Chronic, B-Cell 1771Myelodysplastic Syndromes 1298Hematologic Neoplasms 1067Lymphoma 1029Lymphoma, Non-Hodgkin 981Leukemia, Myelogenous, Chronic, BCR-ABL Positive 713Lymphoma, Follicular 704Lymphoma, Mantle-Cell 678Lymphoma, Large B-Cell, Diffuse 657Burkitt Lymphoma 642Multiple Myeloma 639Lymphoma, B-Cell, Marginal Zone 599Recurrence 587Hodgkin Disease 575Leukemia, Myelomonocytic, Chronic 495Lymphoma, Large-Cell, Immunoblastic 419Neoplasms 402Myeloproliferative Disorders 402Leukemia, Myeloid, Chronic-Phase 391Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 382Congenital Abnormalities 357Waldenstrom Macroglobulinemia 330Blast Crisis 324Leukemia, Myeloid, Accelerated Phase 290Lymphoma, T-Cell, Cutaneous 280Primary Myelofibrosis 270Anemia, Refractory, with Excess of Blasts 251

Interventions

N1-(3-(dimethylamino)propyl)-N8-hydroxy-2-((naphthalene-1-loxy)methyl)oct-2-enediamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Fibrosis × Other hematologic neoplasm × Clear all
NCT05716919 2023-10-23

Multiple Ascending Dose Study of CG200745 'Ivaltinostat' Oral Capsule

Machaon Biotherapeutics, Inc.

Phase 1 Unknown
32 enrolled
Other hematologic neoplasm

Fibrosis, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡